EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Rei Kudo, Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R Dry, Hong Shao, Sharanya Nag, Edaise M da Silva, Selma Yeni Yildirim, Qing Li, Elizabeth O'Connell, Payal Patel und 16 weitere

Cancer Cell · 2024-11 · 42 (11) · 1919-1935.e9

DOI: 10.1016/j.ccell.2024.09.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024-11. Verfasst von Rei Kudo und 27 weiteren Autor:innen. Beteiligte Einrichtung: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA; Department of Surgery, The Jikei Univ…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase 4, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Breast Cancer Research Foundation, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4Tumor Suppressor Protein p53Cyclin-Dependent Kinase 2HumansFemaleCell Line, TumorPhosphorylationAnimalsProtein Kinase InhibitorsProto-Oncogene Proteins c-mdm2Cellular SenescenceMice

Stichwörter der Autor:innen

CDK2CDK4/6breast cancercell cyclecyclin dependent kinasedrug resistancep53quiescencesenescence

Substanzen

Cyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4Tumor Suppressor Protein p53CDK6 protein, humanCDK4 protein, humanCyclin-Dependent Kinase 2TP53 protein, humanCDK2 protein, humanProtein Kinase InhibitorsProto-Oncogene Proteins c-mdm2

Autor:innen und Institutionen

  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA; Department of Surgery, The Jikei University School of Medicine, Tokyo 1058461, Japan.
  • Breast Medicine Service, Department of Medicine, MSK, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA.
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA.
  • Department of Medicine, MSK, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, MSK, New York, NY 10065, USA.
  • Tempus AI, Boston, MA 02110, USA.
  • Department of Pathology and Laboratory Medicine, MSK, New York, NY 10065, USA.

Förderung

  • NCI NIH HHS
  • Breast Cancer Research Foundation
  • Foundation for the National Institutes of Health

Zitieren

APA

Kudo, R., Safonov, A., Jones, C., Moiso, E., Dry, J. R., Shao, H., Nag, S., da Silva, E. M., Yildirim, S. Y., Li, Q., O'Connell, E., Patel, P., Will, M., Fushimi, A., Benitez, M., Bradic, M., Fan, L., Nakshatri, H., Sudhan, D. R., …, & Chandarlapaty, S. (2024). Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer Cell, 42(11), 1919-1935.e9. https://doi.org/10.1016/j.ccell.2024.09.009

Vancouver

Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, et al. Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer Cell. 2024;42(11):1919-1935.e9. doi:10.1016/j.ccell.2024.09.009

BibTeX
@article{Kudo2024,
  author = {Kudo, Rei and Safonov, Anton and Jones, Catherine and Moiso, Enrico and Dry, Jonathan R and Shao, Hong and Nag, Sharanya and da Silva, Edaise M and Yildirim, Selma Yeni and Li, Qing and O'Connell, Elizabeth and Patel, Payal and Will, Marie and Fushimi, Atsushi and Benitez, Marimar and Bradic, Martina and Fan, Li and Nakshatri, Harikrishna and Sudhan, Dhivya R and Denz, Christopher R and Huerga Sanchez, Iker and Reis-Filho, Jorge S and Goel, Shom and Koff, Andrew and Weigelt, Britta and Khan, Qamar J and Razavi, Pedram and Chandarlapaty, Sarat},
  title = {Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion},
  journal = {Cancer Cell},
  year = {2024},
  volume = {42},
  number = {11},
  pages = {1919--1935.e9},
  doi = {10.1016/j.ccell.2024.09.009}
}
Kostenlos starten →